Alvotech's stock added to Nasdaq Biotechnology Index, meeting inclusion criteria

From GlobeNewswire: 2024-12-23 04:00:00

Alvotech’s stock will be added to the Nasdaq Biotechnology Index (NBI) as part of annual reconstitution. Inclusion criteria involve minimum market cap and trading volume. Alvotech, a global biotech company, specializes in biosimilar medicines. The NBI consists of Nasdaq-listed companies in biotechnology or pharmaceuticals, calculated using a modified capitalization-weighted methodology. Companies must meet eligibility requirements for market cap and trading volume to be included. Alvotech’s pipeline includes biosimilar candidates for various disorders and cancers, with commercial partnerships worldwide. For more information, visit Alvotech’s website or contact Investor Relations.



Read more at GlobeNewswire: Alvotech Added to Nasdaq Biotech Index Effective Monday